Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T13:30:28.495Z.
Calculation as of: 2026-10-06T13:30:28.495Z.
Quote observation: 2026-10-06T13:30:04.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 026981202cadb8e73b6cbd63f18abfa8ffa74fea80ac6bbb32512047e0825b9f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$2.68B
PS Ratio
0.80
TTM Avg
0.64
3Y Avg
1.30
5Y Avg
1.84
Market Cap
$2.68B
PS Ratio
1.03
TTM Avg
0.82
3Y Avg
0.54
5Y Avg
0.45
Market Cap
$2.53B
PS Ratio
46.10
TTM Avg
33.48
3Y Avg
36.04
5Y Avg
67.42
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alamar Biosciences, Inc. (ALMR) | $2.69B | N/A | N/A | N/A | N/A |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.68B | 0.80 | 0.64 | 1.30 | 1.84 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.68B | 1.03 | 0.82 | 0.54 | 0.45 |
| Beam Therapeutics Inc. (BEAM)vs › | $2.76B | 17.71 | 30.60 | 21.37 | 5139.80 |
| AtriCure, Inc. (ATRC)vs › | $2.85B | 5.00 | 3.27 | 3.39 | 5.20 |
| TransMedics Group, Inc. (TMDX)vs › | $2.90B | 4.34 | 7.07 | 9.70 | 14.76 |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.53B | 46.10 | 33.48 | 36.04 | 67.42 |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.89B | N/A | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.45B | N/A | N/A | N/A | N/A |
| Clover Health Investments, Corp. (CLOV)vs › | $2.43B | 0.98 | 0.83 | 0.79 | 0.74 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
